Passage BIO, Inc. Quarterly Return On Assets in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Passage BIO, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q2 2024.
  • Passage BIO, Inc. Return On Assets for the quarter ending June 30, 2024 was -52.3 %, a 7.48% decline year-over-year.
  • Passage BIO, Inc. annual Return On Assets for 2023 was -56.2 %, a 18.3% decline from 2022.
  • Passage BIO, Inc. annual Return On Assets for 2022 was -47.5 %, a 5.74% decline from 2021.
  • Passage BIO, Inc. annual Return On Assets for 2021 was -44.9 %, a 45.8% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -52.3 -3.64 -7.48% Apr 1, 2024 Jun 30, 2024
Q1 2024 -51.6 -1.89 -3.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -56.2 -8.67 -18.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -54.8 -3.88 -7.62% Jul 1, 2023 Sep 30, 2023
Q2 2023 -48.7 +3.69 +7.05% Apr 1, 2023 Jun 30, 2023
Q1 2023 -49.8 +0.11 +0.22% Jan 1, 2023 Mar 31, 2023
Q4 2022 -47.5 -2.58 -5.74% Oct 1, 2022 Dec 31, 2022
Q3 2022 -51 -8.29 -19.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -52.4 -13.4 -34.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -49.9 -15 -42.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -44.9 -14.1 -45.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -42.7 -16.2 -61.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -38.9 Apr 1, 2021 Jun 30, 2021
Q1 2021 -34.9 Jan 1, 2021 Mar 31, 2021
Q4 2020 -30.8 Oct 1, 2020 Dec 31, 2020
Q3 2020 -26.4 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.